- Report
- July 2025
- 175 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Report
- July 2025
- 175 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Report
- January 2025
- 175 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1106EUR$1,250USD£956GBP
- Report
- April 2025
- 100 Pages
Global
From €5264EUR$5,950USD£4,552GBP
- Report
- April 2025
- 200 Pages
Global
From €2203EUR$2,490USD£1,905GBP
- Report
- April 2025
- 100 Pages
Global
From €5264EUR$5,950USD£4,552GBP
- Report
- August 2025
- 192 Pages
Global
From €3136EUR$3,545USD£2,712GBP
€3485EUR$3,939USD£3,013GBP
- Report
- August 2025
- 183 Pages
Global
From €3136EUR$3,545USD£2,712GBP
€3485EUR$3,939USD£3,013GBP
- Report
- May 2025
- 175 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Report
- April 2025
- 250 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Report
- March 2025
- 317 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Report
- February 2025
- 200 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Report
- January 2025
- 175 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Report
- February 2025
- 200 Pages
Global
From €3972EUR$4,490USD£3,435GBP
- Report
- September 2025
- 340 Pages
Global
From €5175EUR$5,850USD£4,475GBP
- Report
- August 2025
- 144 Pages
Global
From €2653EUR$2,999USD£2,294GBP
- Report
- June 2025
- 185 Pages
Global
From €3981EUR$4,500USD£3,443GBP
- Report
- March 2025
- 180 Pages
Global
From €3981EUR$4,500USD£3,443GBP
- Report
- May 2025
- 83 Pages
Global
From €3500EUR$4,238USD£3,133GBP

Calcitonin is a hormone produced by the thyroid gland and is used to treat endocrine and metabolic disorders. It is used to treat hypercalcemia, a condition in which the body has too much calcium in the blood, and to treat osteoporosis, a condition in which bones become weak and brittle. Calcitonin is also used to treat Paget's disease, a disorder of the bones. It is available in both injectable and oral forms.
Calcitonin is a relatively small market compared to other endocrine and metabolic disorder drugs. It is used mainly to treat hypercalcemia and osteoporosis, and is not used as widely as other drugs for these conditions.
Some companies in the calcitonin market include Amgen, Eli Lilly, Novartis, and Pfizer. Show Less Read more